SCLX
Scilex Holding Company
NASDAQ: SCLX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$10.52
+21.76% today
Updated 2026-04-30
Market cap
$47.05M
P/E ratio
—
P/S ratio
1.56x
EPS (TTM)
$-36.48
Dividend yield
—
52W range
$4 – $34
Volume
0.0M
Scilex Holding Company (SCLX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-60.42M | $-31.46M | $-28.66M | $-21.26M | $-20.71M | $19.35M | $3.82M |
| Capital expenditures | $584000.00 | $25000.00 | $7000.00 | $2.07M | $330000.00 | $600000.00 | $133000.00 |
| Depreciation | $3.75M | $3.78M | $3.78M | $3.96M | $4.15M | $4.05M | — |
| Stock-based comp | $4.33M | $5.39M | $5.82M | $5.28M | $14.60M | $15.69M | $15.49M |
| Free cash flow | $-61.01M | $-31.49M | $-28.67M | $-23.32M | $-21.04M | $18.75M | $3.68M |
| Investing cash flow | $-17.62M | $-25000.00 | $-139.38M | $-2.07M | $-330000.00 | $-2.67M | — |
| Financing cash flow | $15.78M | $-19.17M | $28.16M | $21.17M | $23.58M | $-18.13M | — |
| Dividends paid | — | — | — | — | $10.00M | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $477410.00 | $-2.15M | — | — | — |